1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
119.74%
Revenue growth above 1.5x 6247.T's 36.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
106.31%
Gross profit growth above 1.5x 6247.T's 59.02%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
630.40%
EBIT growth above 1.5x 6247.T's 17.43%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
476.51%
Operating income growth above 1.5x 6247.T's 286.67%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
531.62%
Net income growth above 1.5x 6247.T's 25.56%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
531.75%
EPS growth above 1.5x 6247.T's 25.56%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
531.75%
Diluted EPS growth above 1.5x 6247.T's 25.56%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-100.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
67.88%
Similar 10Y revenue/share CAGR to 6247.T's 69.73%. Walter Schloss might see both firms benefiting from the same long-term demand.
-1.30%
Negative 5Y CAGR while 6247.T stands at 28.58%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
2.63%
3Y revenue/share CAGR under 50% of 6247.T's 27.24%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
411.01%
Net income/share CAGR above 1.5x 6247.T's 139.53% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-8.27%
Negative 5Y net income/share CAGR while 6247.T is 85.43%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-18.72%
Negative 3Y CAGR while 6247.T is 310.33%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
127.28%
10Y equity/share CAGR above 1.5x 6247.T's 38.06%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
43.12%
5Y equity/share CAGR above 1.5x 6247.T's 19.61%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
27.25%
3Y equity/share CAGR above 1.5x 6247.T's 12.29%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
28.72%
AR growth well above 6247.T's 5.78%. Michael Burry fears inflated revenue or higher default risk in the near future.
-27.32%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.69%
Asset growth well under 50% of 6247.T's 10.14%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
8.24%
BV/share growth above 1.5x 6247.T's 3.96%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
7.36%
Debt shrinking faster vs. 6247.T's 4745.19%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
12.22%
R&D growth drastically higher vs. 6247.T's 14.29%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
41.42%
SG&A growth well above 6247.T's 7.47%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.